Explicyte Immuno-Oncology - Cancer Immunotherapy CRO Services
Cancer Immunotherapy CRO Services
Discovery
Custom biospecimen sourcing
Target identification
Target expression profiling
Preclinical
Tumor killing
Tumor sensitization
Activation & immune checkpoint inhibition
Antibody-dependent cell cytotoxicity (ADCC)
Tumor antigen-specific killing
Bispecific T cell engager (BiTE) killing
Antibody-Drug Conjugate (ADC) killing
Immuno-modulation
Immune cell activation
Immune cell migration
Mixed lymphocyte reaction (MLR)
Macrophage assays
TLS-GC reaction
Cytokine release syndrome
Featured
Xenium for cells
Trials
Biomarker analysis
TLS detection & evaluation
Platforms
Spatial Biology
Xenium: Single-cell spatial transcriptomics
GeoMx: Digital spatial profiling
Visium HD: Whole-Transcriptome Spatial Biology
IHC/IF: Digital pathology
Multi-Omics
Single-cell RNA Seq
Proteomics
Flow cytometry
About
About Explicyte
Science
Commitments
News
Careers
Contact us
Toggle menu
Contact us
Posts classified under:
In vivo
Explicyte Immuno-Oncology
>
CRO Services
>
In vivo
View Details
Syngeneic Tumor Models for the In Vivo Assessment Cancer Immunotherapies
View Details
In Vivo Models Of CTLA-4 Blockade
View Details
In Vivo Models Of PD-1/PD-L1 Axis Blockade
View Details
In Vivo immunization tumor models
View Details
Sarcoma
View Details
Renal Cancer
View Details
Glioma
View Details
Colon cancer
View Details
Colon Cancer
View Details
Triple Negative Breast Cancer
View Details
Breast Cancer
View Details
In Vivo Models
WordPress Lightbox
